Oromucosal drug delivery: Implementation of standardized and physiologically relevant ex vivo permeation studies in preclinical drug development
- Weitere Titel
-
Oromukosale Arzneimittelabgabe: Implementierung von standardisierten und physiologisch relevanten ex vivo Permeationsstudien in der präklinischen Arzneimittelentwicklung
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2021
- Schlagwort
-
Drug development
- Ereignis
-
Veröffentlichung
- (wo)
-
Düsseldorf
- (wer)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
-
Kübler, Norbert
- URN
-
urn:nbn:de:hbz:061-20220301-111530-9
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Majid, Haidara
- Kübler, Norbert
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Entstanden
- 2022
Ähnliche Objekte (12)
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Molecular models for drug permeation across phospholipid membranes
Physiologically based dissolution tests : experiences with poorly soluble drugs
Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib
Standardized warfarin monitoring decreases adverse drug reactions
Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Molecular models for drug permeation across phospholipid membranes
Physiologically based dissolution tests : experiences with poorly soluble drugs
Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib
Standardized warfarin monitoring decreases adverse drug reactions
Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Molecular models for drug permeation across phospholipid membranes
Physiologically based dissolution tests : experiences with poorly soluble drugs
Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib
Standardized warfarin monitoring decreases adverse drug reactions
Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions